Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Shangjun Teng
Introduction
Shangjun Teng is a notable inventor based in Changshu, China. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His work has led to advancements that are beneficial in various medical applications.
Latest Patents
Shangjun Teng holds a patent for a chemical process for preparing spiroindolones and intermediates thereof. This invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds, such as (1'R,3′S)-5,7′-dichloro-6′-fluoro-3′-methyl-2′,3′,4′,9′-tetrahydrospiro[indoline-3,1′-pyrido[3,4-b]indol]-2-one and its salts, hydrates, and solvates. This patent showcases his expertise in chemical processes and their applications in drug development.
Career Highlights
Shangjun Teng is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to work on innovative solutions that address critical health challenges. His contributions to the field have been recognized within the industry, highlighting his commitment to advancing pharmaceutical science.
Collaborations
Shangjun Teng collaborates with esteemed colleagues, including Michael Crowe and Michael Foulkes. These partnerships enhance the research and development efforts at Novartis, fostering an environment of innovation and creativity.
Conclusion
Shangjun Teng's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patent on spiroindolones represents a significant advancement in chemical processes, contributing to the development of new therapeutic options. His collaborations and career at Novartis further underscore his dedication to improving healthcare through innovation.